Inogen Appoints Mira Kirti Sahney to Board, Enhancing Leadership in Respiratory Care

Inogen Welcomes Mira Kirti Sahney to Board of Directors, Strengthening Leadership in Respiratory Care

Inogen, Inc., a leading medical technology company specializing in innovative respiratory products for homecare, announces the appointment of Mira Kirti Sahney to its Board of Directors, effective January 31, 2025. This development follows the retirement of Tom West, who has been a board member since April 2023. The transition reflects Inogen's commitment to enhancing its governance and leadership structure as it navigates the evolving landscape of respiratory care. Elizabeth Mora, the Chairperson of the Board, expresses optimism regarding Sahney’s extensive management and operational experience in the medical device sector, which is expected to further solidify Inogen’s position as a global leader in respiratory care.

Sahney brings a wealth of experience to Inogen, having held significant roles within the medical device industry. Her tenure as President of the Pelvic Health Operating Unit at Medtronic from 2021 to 2024 has equipped her with a strong understanding of the complexities of the healthcare landscape. Additionally, her leadership experiences at Hyalex Orthopaedics and Smith + Nephew further underline her capability in driving innovation and operational efficiency. As a co-founder of Myomo, Inc., a wearable medical robotics company, Sahney has also demonstrated her entrepreneurial acumen, suggesting a capacity for strategic thinking and market adaptation. With a robust educational background that includes a B.S. in Mechanical Engineering from the University of Michigan and multiple advanced degrees from Stanford University and MIT, Sahney is well-prepared to contribute to Inogen's mission of advancing respiratory care.

In her statement regarding her new role, Sahney expresses gratitude for the opportunity and emphasizes her commitment to enhancing shareholder value and improving patient care solutions. As a crucial part of her responsibilities, she will serve on the Compliance and Nominating and Governance Committees of the Board. This appointment comes at a pivotal time for Inogen, as the company continues to innovate and market best-in-class respiratory therapy devices aimed at supporting patients with respiratory conditions. By integrating Sahney's expertise into its leadership, Inogen aims to accelerate its growth trajectory and reinforce its commitment to providing superior respiratory care.

Inogen remains focused on its mission to enhance the quality of life for patients with respiratory challenges. The company’s dedication to developing cutting-edge respiratory therapy devices positions it as a key player in the healthcare industry, ready to meet the growing demands of patients and healthcare providers alike. With the addition of Mira Kirti Sahney to its Board of Directors, Inogen is poised to further strengthen its operational capabilities and governance as it continues to drive forward in the respiratory care sector.